V

Veracyte
D

VCYT

25.260
USD
1.65
(6.99%)
مغلق
حجم التداول
441,782
الربح لكل سهم
1
العائد الربحي
-
P/E
60
حجم السوق
1,978,227,074
أصول ذات صلة
A
ADPT
0.100
(0.94%)
10.760 USD
BMRN
BMRN
-0.765
(-1.28%)
59.010 USD
DXCM
DXCM
2.230
(2.57%)
88.980 USD
F
FATE
-0.01000
(-0.80%)
1.23500 USD
REGN
REGN
-1.20
(-0.21%)
563.22 USD
R
RGEN
-0.200
(-0.16%)
121.670 USD
T
TDOC
0.01000
(0.12%)
8.21000 USD
VEEV
VEEV
-0.77
(-0.26%)
290.48 USD
المزيد
الأخبار المقالات

العنوان: Veracyte

القطاع: Healthcare
الصناعة: Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.